Delivery Order SPE2DB20D1050-SPE2DB25FH46K

Award Date 1/23/25
Potential Completion Date 1/24/25
Potential Value $9.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 28, 2022. The $2,177.29 delivery order is for the supply of Veltassa 16.8 GM Powder Packets, a specialty medication. The contract has a firm fixed price and an ultimate completion date of June 29, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,456.26 Firm Fixed Price Delivery Order, awarded on December 9, 2024, is for the supply of Veltassa 8.4 GM Powder Packets. The contract has an ultimate completion date of December 10, 2024 and was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,230.67 Firm Fixed Price Delivery Order is for the supply of VELTASSA 16.8 GM POWDER PACKET 30S, a pharmaceutical product. The contract has an ultimate completion date of December 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Veltassa 8.4 GM powder packets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,664.28 and is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,358.10, is for the delivery of the medication Veltassa 8.4 GM Powder Packet 30s. This is a firm fixed-price delivery order contract that runs through February 28, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,819.44 firm fixed-price delivery order is for the supply of VELTASSA 8.4 GM POWDER PACKET 30S, a medical product. The contract has an ultimate completion date of October 10, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,075.68 firm fixed-price delivery order is for the provision of VELTASSA 8.4 GM POWDER PACKET 30S, a specialty pharmaceutical product. The contract has a completion date of February 9, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $27,312.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of VELTASSA 8.4 GM POWDER PACKET 30S, a pharmaceutical product. The contract has an ultimate completion date of May 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This award to Amerisourcebergen Drug Corp is a delivery order contract (SPE2DB22D1041|SPE2DB25FTYS8) with the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Veltassa 8.4 GM powder packets. The $1,386.99 firm fixed price contract has a completion date of December 10, 2024. Amerisourcebergen, a major pharmaceutical distributor, is an established vendor for the DLA, holding a $999,999,999 Indefinite Delivery Contract (IDC) to provide a wide range of medical commodities to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,936.65, is for the supply of VELTASSA 8.4 GM POWDER PACKET 30S, a pharmaceutical product, with a completion date of June 20, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
  • SPE2DB20D1050
    Indefinite Delivery Contract
  • SPE2DB20D1050-SPE2DB25FH46K
    Delivery Order

This federal contract award, identified as SPE2DB20D1050|SPE2DB25FH46K, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Veltassa 8.4 GM Powder Packets, a specialized medication, with a ceiling value of $9,385.01 and an ultimate completion date of January 24, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 4/24/25, 11:06 AM